arrow
U

Umberto Vitolo

irccs candiolo cancer institute
H指数:76
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RENOIR phase 3 rituximab-lenalidomide vs rituximab as maintenance treatment in relapsed/refractory follicular lymphoma

RENOIR三期研究:利妥昔单抗-来那度胺对比利妥昔单抗作为复发/难治性滤泡性淋巴瘤的维持治疗

2026-09-010
PRE
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial

自体移植后复发/难治性滤泡性淋巴瘤患者继发恶性肿瘤风险增加:FIL-FLAZ12 III期试验的长期结果

2026-08-120
OAAI
First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma

使用epcoritamab联合 bendamustine和rituximab的一线治疗在滤泡性淋巴瘤患者中诱导了超过3年的持续缓解

2026-08-050
OAAI
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up

弥漫大B细胞淋巴瘤(LBCL):EHA 诊断、治疗和随访临床实践指南

2025-09-230
OAAI
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe

弥合欧洲大B细胞淋巴瘤疗法在临床试验可及性和报销方面的差距

2025-09-230
OAAI
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma

BCL-2介导的rRNA合成下调可诱导弥漫性大B细胞淋巴瘤产生化疗耐药性

2025-05-010
OAAI
Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients

FIL MCL0208试验中,来那度胺维持治疗与观察在MCL患者自体干细胞移植(ASCT)后的长期结果

2025-03-220
OAAI
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Epcoritamab联合GemOx在移植不合格的复发/难治性DLBCL中的应用:EPCORE NHL-2试验的结果

BLOOD
IF23.1
2025-01-103
OA
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

Epcoritamab单药治疗复发性或难治性滤泡性淋巴瘤患者 (EPCORE NHL-1): 单臂多中心研究的2期队列

2024-08-018
PRE
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial
2024-05-252
PRE
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
2024-03-189
OAAI
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial

放射免疫疗法与自体造血干细胞移植治疗复发/难治性滤泡性淋巴瘤: 一项多中心,随机,III期临床试验

2024-01-010
OA
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naive advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi
2023-05-285
OA
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
2022-11-3013
OAAI